INTERNATIONAL PATENT: SYNTEKABIO, INC., (주)신테카바이오 FILES APPLICATION FOR "PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DEPRESSION- OR ANXIETY-RELATED DISEASES, COMPRISING LAZERTINIB OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF"

GENEVA, Oct. 5 -- SYNTEKABIO, INC. (18 Gukjegwahak 17-ro,Yuseong-gu, Daejeon 34002), (주)신테카바이오 (대전광역시유성구국제과학17로 18) filed a patent application (PCT/KR2025/003833) for "PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DEPRESSION- OR ANXIETY-RELATED DISEASES, COMPRISING LAZERTINIB OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF" on Mar 26, 2025. With publication no. WO/2025/206726, the details related to the patent application was published on Oct 02, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual...